uterine cancer (Cancer)

Search with Google Search with Bing
Information
Disease name
uterine cancer
Disease ID
DOID:363
Description
"A female reproductive organ cancer that is located_in the uterus." [url:http\://www.cancer.gov/dictionary?CdrID=445094]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03934827 Active, not recruiting Phase 1 MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour April 10, 2019 December 31, 2022
NCT04383210 Active, not recruiting Phase 2 Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors September 29, 2020 March 2025
NCT03668340 Active, not recruiting Phase 2 AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma October 22, 2018 December 31, 2025
NCT04398446 Active, not recruiting Phase 2 Effect of Hemp-CBD on Patients With CIPN May 27, 2020 April 1, 2023
NCT05939440 Active, not recruiting N/A Interventions to Decrease Financial Toxicity June 1, 2022 May 26, 2025
NCT04681248 Available Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
NCT06401265 Completed Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC) January 1, 2018 September 5, 2022
NCT00508703 Completed Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy March 5, 2003 September 8, 2017
NCT00581646 Completed Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance September 2006 June 2015
NCT00584857 Completed Phase 2 A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer July 2004 October 2011
NCT00588276 Completed Phase 1 Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors June 2005 June 2012
NCT00588640 Completed Phase 1/Phase 2 Study of D-Methadone in Patients With Chronic Pain October 2004 July 2008
NCT00614835 Completed N/A Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus August 2001 January 2012
NCT05529303 Completed N/A Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients February 26, 2023 September 18, 2023
NCT00706875 Completed A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors June 2008 April 2018
NCT00746018 Completed N/A Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy August 2008 July 2017
NCT00870233 Completed Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life March 24, 2009 February 12, 2018
NCT00944944 Completed Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema July 2009 January 2010
NCT01163552 Completed Phase 2 Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity June 2010 May 2014
NCT04604158 Completed N/A Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients December 2, 2020 May 17, 2024
NCT04492007 Completed N/A Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) November 2, 2020 December 20, 2021
NCT01370122 Completed Pelvic Floor Disorders in Survivors of Gynecologic Malignancies May 2011 September 2017
NCT01399658 Completed Phase 2 Image-Guided Gynecologic Brachytherapy September 2011 June 2016
NCT01432015 Completed Phase 4 Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting September 2011 March 2015
NCT01492179 Completed Phase 4 Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. November 2011 June 2013
NCT01570218 Completed N/A Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy February 2010 February 2011
NCT00231868 Completed Phase 2 A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma December 2001 July 2011
NCT03701529 Completed N/A Effect of Anesthetic Agents on Optic Nerve Sheath Diameter October 15, 2018 September 16, 2019
NCT03604653 Completed Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers May 15, 2018 May 1, 2021
NCT03662204 Completed Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors August 23, 2018 March 31, 2022
NCT00284427 Completed Phase 2 Safety of Antioxidants During GYN Cancer Care September 2005 December 2006
NCT00444054 Completed N/A The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer February 2006 May 2012
NCT03241745 Completed Phase 2 A Study of Nivolumab in Selected Uterine Cancer Patients August 3, 2017 April 1, 2024
NCT03285802 Completed Phase 2/Phase 3 Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation September 7, 2017 February 12, 2019
NCT03395080 Completed Phase 2 A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma March 5, 2018 January 27, 2021
NCT00275353 Completed Phase 2 Effectiveness of an Individualized Symptom Education Program (ISEP) July 2003 February 2006
NCT01601548 Completed N/A Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy July 2012 July 2013
NCT01709175 Completed N/A Strength Training Study for Survivors of Breast and Gynecologic Cancer November 2012 January 2015
NCT01870947 Completed N/A Assisted Exercise in Obese Endometrial Cancer Patients September 7, 2011 September 4, 2019
NCT01953107 Completed Phase 4 Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. November 2013 December 2020
NCT01962272 Completed Phase 4 The Effect of Nutritional Counseling for Cancer Patients January 2010 September 2010
NCT02069769 Completed N/A Ensuring Communication in Hospice by Oncology Study (ECHO) January 2014 January 2017
NCT04363957 Completed N/A Evaluation of Patient Reported Knowledge and Satisfaction Following the Use of an Enhanced Gynecologic Brachytherapy-Specific Educational Video April 1, 2020 April 22, 2022
NCT02209532 Completed N/A A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping December 2015 June 2017
NCT04262089 Completed Phase 1 Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study November 1, 2020 November 1, 2023
NCT04068675 Completed N/A Effects of Centering Pre-operative Counseling on Patient Reported Anxiety February 24, 2020 June 30, 2021
NCT02465892 Completed N/A Pillars4Life Trial May 2015 October 2016
NCT02531997 Completed N/A A Mind-body Intervention to Improve Body and/or Self Image August 2015 December 2017
NCT02714621 Completed N/A MR-HIFU for Recurrent Gynaecological Cancer May 2016 March 31, 2020
NCT02725489 Completed Phase 2 Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers June 3, 2016 December 2, 2020
NCT02896413 Completed N/A The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection June 2, 2016 October 24, 2018
NCT00147680 Completed Phase 2 Uterine Papillary Serous Cancer (UPSC) Trial September 2004 October 2009
NCT00231842 Completed Phase 2 Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus February 2003 July 2011
NCT03813719 Completed Anxiety and Distress Levels in Women With Suspected Endometrial Cancer July 1, 2018 August 1, 2019
NCT03073525 Completed Phase 2 A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers May 31, 2017 May 18, 2022
NCT03192059 Completed Phase 2 Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer July 1, 2017 June 30, 2021
NCT03762733 Enrolling by invitation Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies January 4, 2022 December 29, 2028
NCT05998811 Not yet recruiting Insights Into Participating in Studies for Uterine Cancer September 2024 September 2026
NCT06369155 Not yet recruiting Phase 2 Azenosertib in Uterine Serous Carcinoma: Biomarker Study September 2024 January 31, 2027
NCT06392997 Not yet recruiting Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology June 2024 June 2026
NCT06447064 Recruiting Cancer Loyalty Card Study 2 (CLOCS-2) April 29, 2024 March 31, 2027
NCT02986568 Recruiting N/A Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers May 10, 2016 December 31, 2025
NCT02993900 Recruiting N/A Image-Guided Gynecologic Brachytherapy December 15, 2016 December 2028
NCT03476681 Recruiting Phase 1/Phase 2 Study of NEO-201 in Solid Tumors Expansion Cohorts January 18, 2019 October 15, 2026
NCT03556228 Recruiting Phase 1 Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma June 8, 2018 June 2026
NCT03702309 Recruiting Liquid Biopsy Evaluation and Repository Development at Princess Margaret August 3, 2017 July 6, 2024
NCT03924466 Recruiting Phase 2 Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients April 1, 2019 December 2024
NCT04028479 Recruiting The Registry of Oncology Outcomes Associated With Testing and Treatment May 5, 2021 October 1, 2031
NCT04038619 Recruiting Phase 1 Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients February 1, 2021 December 31, 2025
NCT05220033 Recruiting N/A Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer July 14, 2020 December 1, 2025
NCT05344950 Recruiting Connecting Audio and Radio Sensing Systems to Improve Care at Home March 21, 2022 July 2025
NCT05559879 Recruiting Phase 1/Phase 2 Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma August 20, 2023 December 2025
NCT05697198 Recruiting PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine April 19, 2021 September 2024
NCT05708950 Recruiting Phase 1/Phase 2 A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) March 3, 2023 December 31, 2024
NCT05738902 Recruiting Adherence and Compliance to ERAS in Gynecological Surgery May 30, 2023 March 31, 2025
NCT05743517 Recruiting N/A Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) September 15, 2023 August 1, 2029
NCT05758688 Recruiting N/A Whole Pelvis Proton Radiation for Gynecologic Cancer November 6, 2023 March 2026
NCT05864144 Recruiting Phase 1/Phase 2 A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors May 31, 2023 June 2027
NCT05916196 Recruiting Phase 2 [18F]FES PET/.CT in Uterine Cancer September 1, 2023 August 1, 2026
NCT05976113 Recruiting A Retrospective Study on Multiple Classifier Endometrial Cancer July 27, 2023 August 31, 2023
NCT05977621 Recruiting Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking February 7, 2024 February 2025
NCT05990426 Recruiting N/A Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy October 16, 2023 August 2026
NCT06024109 Recruiting Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy March 19, 2024 January 2026
NCT06203106 Recruiting NYSCF Scientific Discovery Biobank November 10, 2022 November 10, 2045
NCT03842865 Temporarily not available Expanded Access of Vigil in Solid Tumors
NCT01010334 Terminated N/A Comparison of Standard of Care or Treatment on Protocol March 2009 July 2011
NCT01284075 Terminated N/A The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery April 2010 April 2013
NCT00582205 Terminated Phase 2 Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma January 2006 December 2011
NCT00506779 Terminated Phase 1/Phase 2 Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma December 29, 2003 April 2015
NCT00626561 Terminated Phase 2 Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix February 2008 July 2011
NCT03694834 Terminated Early Phase 1 Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer March 29, 2019 October 23, 2023
NCT00584909 Terminated Phase 2 A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus March 2006 September 2011
NCT03423082 Terminated Phase 4 Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer. December 11, 2018 December 18, 2019
NCT00471120 Terminated N/A Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer November 2006 February 2008
NCT00231829 Terminated Phase 2 A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers April 2003 March 2004
NCT04424641 Terminated Phase 1/Phase 2 A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors July 15, 2020 October 29, 2021
NCT03021200 Unknown status N/A Laser Fluorescence in Cancer Surgical Treatment July 12, 2016 December 10, 2020
NCT03896958 Unknown status The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) March 21, 2019 March 12, 2024
NCT01650376 Unknown status Phase 1/Phase 2 Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer August 2012 December 2019
NCT02952183 Unknown status N/A Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors July 2015
NCT04849858 Unknown status Phase 3 Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures May 20, 2019 June 2022
NCT01600040 Unknown status N/A Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix May 2013 September 2023
NCT02458001 Unknown status N/A Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer July 2015 March 2017
NCT04239443 Unknown status Phase 2 Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer January 30, 2019 March 31, 2022
NCT02349958 Unknown status Phase 2 Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy September 2006 January 2022
NCT00588263 Withdrawn Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer July 2000 July 2018
NCT01176500 Withdrawn Phase 1/Phase 2 A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors July 28, 2010 November 18, 2011
NCT03583736 Withdrawn N/A Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer June 27, 2018 June 1, 2020
NCT02095847 Withdrawn Phase 2 High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection March 2015
NCT04368130 Withdrawn N/A SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care September 1, 2022 September 1, 2023
Disase is a (Disease Ontology)
DOID:120
Cross Reference ID (Disease Ontology)
ICD10CM:C55
Cross Reference ID (Disease Ontology)
ICD9CM:179
Cross Reference ID (Disease Ontology)
MESH:D014594
Cross Reference ID (Disease Ontology)
NCI:C3435
Cross Reference ID (Disease Ontology)
NCI:C3552
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:126908007
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:371973000
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0042138
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0153567
Exact Synonym (Disease Ontology)
CA - cancer of uterus
Exact Synonym (Disease Ontology)
malignant neoplasm of uterus
Exact Synonym (Disease Ontology)
malignant uterine tumor
Exact Synonym (Disease Ontology)
neoplasm of uterus
Exact Synonym (Disease Ontology)
Tumour of uterus
Exact Synonym (Disease Ontology)
uterine tumor
Exact Synonym (Disease Ontology)
uterus neoplasm